U. S. authorities on Wednesday approved Medtronic’s $43 billion merger with Covidien after requiring the spinoff of a drug-coated catheter business.
WSJ.com: What's News US, Wall Street Journal
Wed, 11/26/2014 - 1:45pm
U. S. authorities on Wednesday approved Medtronic’s $43 billion merger with Covidien after requiring the spinoff of a drug-coated catheter business.